TCL Archive In this 16-page issue: The Wall Street Journal editorial page leads campaign against efficacy standard. August 5, 2005
TCL Archive DCT Board Approves Three New BRMP RFAs For Immunologic Research, $1.5 Million A Year February 27, 1987
TCL Archive FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says. March 4, 2005
TCL Archive ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma. December 10, 2004